# Thomas Glocer (1959)

> Double Lead Director: guida i board di Merck ($64B pharma) e Morgan Stanley ($177B bank), ex-CEO Thomson Reuters, CFR member

## Dati Essenziali

| Aspetto | Dettaglio |
|---------|-----------|
| **Nascita** | 8 ottobre 1959, New York City, USA |
| **Nazionalita'** | USA |
| **Residenza** | New York |

---

## Formazione

| Periodo | Istituzione | Dettaglio |
|---------|-------------|-----------|
| **1977-1981** | [Columbia University](../university/columbia.md) | BA Political Science |
| **1981-1984** | [Yale Law School](../university/yale-law-school.md) | JD |

**Note:**
- Bar di New York 1984
- Bar della Corte Suprema USA 2010
- American Law Institute 2011
- Interesse precoce per computing durante gli studi a Columbia
- Lavoro su gamification della legal education a Yale CS

---

## Carriera e Ruoli

### Timeline Professionale

| Periodo | Ruolo | Organizzazione |
|---------|-------|----------------|
| **1984-1993** | M&A Lawyer | [Davis Polk & Wardwell](../company/davis-polk.md) |
| **1993-2001** | VP, Deputy Counsel, President Americas | [Reuters](../media/thomson-reuters.md) |
| **2001-2008** | CEO | Reuters Group PLC |
| **2008-2011** | CEO | [Thomson Reuters](../media/thomson-reuters.md) |
| **2012-** | Board, Lead Director | [Morgan Stanley](../bank/morgan-stanley.md) |
| **2007-** | Board, Lead Director | [Merck & Co.](../pharma/merck.md) |
| **2017-** | Co-founder, Executive Chairman | [BlueVoyant](../company/bluevoyant.md) |

### Post-Thomson Reuters: Imprenditore e Investitore

| Veicolo | Ruolo | Focus |
|---------|-------|-------|
| **BlueVoyant** | Co-founder, Executive Chairman | Cybersecurity |
| **Capitolis** | Co-founder, Executive Chairman | Fintech |
| **Communitas Capital** | Partner | VC early-stage fintech |
| **Angelic Ventures** | Founder, Managing Partner | Family office: fintech, media, healthcare |
| **ISTARI** | Chairman | Cyber risk management |
| **Afiniti** | Advisory Board | AI/Big Data |

---

## Rete di Connessioni

### Mappa delle Appartenenze

```
                    THOMAS GLOCER
                         |
      +------------------+------------------+
      |                  |                  |
      v                  v                  v
  CORPORATE          FORUMS/             VENTURES
  BOARDS            THINK TANKS          (2012-)
      |                  |                  |
  +---+---+         +----+----+        +---+---+
  |       |         |    |    |        |       |
Merck  Morgan    CFR  Atlantic  BlueVoyant Angelic
(Lead)  Stanley     Council            Ventures
        (Lead)
```

### The Double Lead Director Pattern

| Board | Ruolo | Dal | Note |
|-------|-------|-----|------|
| **Merck & Co.** | Lead Director | 2007 | $64B pharma |
| **Morgan Stanley** | Lead Director | 2017 | $177B bank |
| **Publicis Groupe** | Director | - | $15B advertising |

**Pattern raro**: Lead Director simultaneo di una major pharma E una major bank. Posizione non-CEO ma con potere significativo: guida i director indipendenti, interfaccia con CEO.

### Forum e Think Tank

| Forum | Ruolo |
|-------|-------|
| [CFR](../think-tank/cfr.md) | Member (former Director) |
| [Atlantic Council](../think-tank/atlantic-council.md) | Member |
| Yale President's Council on International Activities | Member |
| Yale Law School Executive Committee | Member |
| Madison Council, Library of Congress | Member |

### Network Professionale

| Nome | Connessione |
|------|-------------|
| [James Gorman](james-gorman.md) | Collega Morgan Stanley, CEO durante suo Lead Director tenure |
| [David Thomson](david-thomson.md) | Chairman Thomson Reuters durante sua CEO tenure |
| [Robert Davis](robert-davis.md) | CEO Merck, lavora con lui come Lead Director |
| [Kathy Warden](kathy-warden.md) | Fellow board member Merck |

---

## Potere Esercitato

### The Connector Role

| Settore | Posizione | Potere |
|---------|-----------|--------|
| **Media** | Ex-CEO Thomson Reuters | Controllo flusso informazioni finanziarie globali |
| **Finance** | Lead Director Morgan Stanley | Oversight $177B bank |
| **Pharma** | Lead Director Merck | Oversight $64B pharma |
| **Cybersecurity** | Chairman BlueVoyant | Accesso infrastruttura sicurezza |
| **Foreign Policy** | CFR Member | Network establishment |

### Pattern: Media-Finance-Pharma Triangle

```
         MEDIA (Thomson Reuters)
              CEO 2001-2011
                    |
                    v
     +--------- GLOCER ----------+
     |                           |
     v                           v
FINANCE                       PHARMA
Morgan Stanley               Merck
Lead Director                Lead Director
```

**Implicazione**: Una persona collega direttamente i tre settori che controllano informazione, capitale e salute.

---

## Citazioni

> "I've always been fascinated by the intersection of technology and human behavior."
> â€” Thomas Glocer

---

## Connessioni PowerLink

### Organizzazioni

| Entita' | Connessione |
|---------|-------------|
| [Thomson Reuters](../media/thomson-reuters.md) | CEO 1993-2011 |
| [Morgan Stanley](../bank/morgan-stanley.md) | Lead Director 2012- |
| [Merck & Co.](../pharma/merck.md) | Lead Director 2007- |
| [CFR](../think-tank/cfr.md) | Member |
| [Atlantic Council](../think-tank/atlantic-council.md) | Member |
| [BlueVoyant](../company/bluevoyant.md) | Co-founder 2017- |
| [Publicis Groupe](../company/publicis.md) | Board |
| [Cleveland Clinic](../company/cleveland-clinic.md) | Trustee |
| [Davis Polk & Wardwell](../company/davis-polk.md) | M&A lawyer 1984-1993 |
| [Columbia University](../university/columbia.md) | Alumni BA 1981 |
| [Yale Law School](../university/yale-law-school.md) | Alumni JD 1984 |

### Persone

| Persona | Relazione |
|---------|-----------|
| [James Gorman](james-gorman.md) | Collega Morgan Stanley |
| [David Thomson](david-thomson.md) | Collega Thomson Reuters |
| [Robert Davis](robert-davis.md) | CEO Merck |

---

## Timeline

| Anno | Evento |
|------|--------|
| **1959** | Nascita, New York City |
| **1981** | BA Political Science, Columbia |
| **1984** | JD Yale Law School, entra Davis Polk |
| **1993** | Lascia Davis Polk, entra Reuters come VP & Deputy Counsel |
| **2001** | CEO Reuters Group PLC |
| **2007** | Entra board Merck (diventa Lead Director) |
| **2008** | CEO Thomson Reuters (post-merger) |
| **2011** | Lascia Thomson Reuters |
| **2012** | Entra board Morgan Stanley |
| **2017** | Co-fonda BlueVoyant, diventa Lead Director Morgan Stanley |
| **2025** | Continua come Double Lead Director (Merck + Morgan Stanley) |

---

## Fonti

### Biografie
- [Wikipedia - Tom Glocer](https://en.wikipedia.org/wiki/Tom_Glocer)
- [Yale Law School - Alumni Profile](https://law.yale.edu/studying-law-yale/alumni-student-profiles/thomas-h-glocer-84)

### Istituzioni
- [BlueVoyant - Leadership](https://www.bluevoyant.com/team/thomas-glocer/)
- [Communitas Capital](https://communitascapital.com/tom-glocer/)
- [K2 Intelligence - Profile](https://www.k2intelligence.com/en/people/professionals/glocer-h-thomas)

### Investimenti
- [PitchBook - Investment Portfolio](https://pitchbook.com/profiles/investor/107516-53)
- [Crunchbase - Angelic Ventures](https://www.crunchbase.com/person/tom-glocer)

---

*Ultimo aggiornamento: Febbraio 2025*
